MyAverix Finance
NS · Healthcare
Kabra Drugs Ltd (524322)
Pharmaceuticals & Biotechnology
Kabra Drugs Ltd (524322) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $557.10M, P/E ratio is 11.32, net margin is -54.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524322
Kabra Drugs Ltd (524322) — FAQ
What is Kabra Drugs Ltd's market cap?
Kabra Drugs Ltd (524322) has a reported market cap of $557.10M (data as of 2026-07-10).
What is 524322's P/E ratio?
The price-to-earnings (P/E) ratio for Kabra Drugs Ltd (524322) is 11.32 (data as of 2026-07-10).
Does Kabra Drugs Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Kabra Drugs Ltd (524322). Check the MyAverix Finance app for the latest dividend data.
What sector is Kabra Drugs Ltd in?
Kabra Drugs Ltd (524322) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524322 listed on?
524322 is listed on NS.
What is Kabra Drugs Ltd's net margin?
Kabra Drugs Ltd (524322) reports a net margin of -54.8% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.